BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pinto-de-Sousa J, Silva F, David L, Leitão D, Seixas M, Pimenta A, Cardoso-de-Oliveira M. Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma. Histopathology 2004;44:323-31. [PMID: 15049897 DOI: 10.1111/j.1365-2559.2004.01852.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lordick F, Schulze T, Jäger D. The role of biologics in stomach cancer. Targ Oncol 2008;3:71-9. [DOI: 10.1007/s11523-008-0078-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Ahadi M, Moradi A, Musavinejad L, Movafagh A, Moradi A. The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study. Asian Pac J Cancer Prev 2020;21:1607-14. [PMID: 32592354 DOI: 10.31557/APJCP.2020.21.6.1607] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Nitti D, Mocellin S, Marchet A, Pilati P, Lise M. Recent advances in conventional and molecular prognostic factors for gastric carcinoma. Surg Oncol Clin N Am 2008;17:467-83, vii. [PMID: 18486878 DOI: 10.1016/j.soc.2008.02.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
4 Zulfiqar M, Bluth MH, Bhalla A. Molecular Diagnostics in Esophageal and Gastric Neoplasms: 2018 Update. Clin Lab Med 2018;38:357-65. [PMID: 29776635 DOI: 10.1016/j.cll.2018.02.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Deveci MS, Deveci G. Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma. Gastric Cancer. 2007;10:112-116. [PMID: 17577621 DOI: 10.1007/s10120-007-0418-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
6 Song KY, Jung CK, Park WS, Park CH. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma. Jpn J Clin Oncol. 2009;39:290-296. [PMID: 19336448 DOI: 10.1093/jjco/hyp020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
7 Agrawal A, Yang J, Murphy RF, Agrawal DK. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer. Exp Mol Pathol. 2006;81:115-122. [PMID: 16919268 DOI: 10.1016/j.yexmp.2006.07.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 3.4] [Reference Citation Analysis]
8 Kim B, Byun SJ, Kim YA, Kim JE, Lee BL, Kim WH, Chang MS. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas. Pathology. 2010;42:58-65. [PMID: 20025482 DOI: 10.3109/00313020903356392] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
9 Cho M, Eze O, Xu R. Molecular genetics of gastric adenocarcinoma in clinical practice. World J Med Genet 2014; 4(3): 58-68 [DOI: 10.5496/wjmg.v4.i3.58] [Reference Citation Analysis]
10 Zulfiqar M, Bhalla A, Weindel M, Shidham VB. Molecular diagnostics in esophageal and gastric neoplasms. Clin Lab Med. 2013;33:867-873. [PMID: 24267191 DOI: 10.1016/j.cll.2013.08.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
11 Xu L, Sun DZ, He J, Liu L, Wei PK. Expression of tumor metastasis-related gene protein in the same syndromic classification of gastric carcinoma on traditional Chinese medicine. Shijie Huaren Xiaohua Zazhi 2004; 12(12): 2782-2787 [DOI: 10.11569/wcjd.v12.i12.2782] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
12 Kim S, Kim YJ, Chung WC. HER-2 positivity is a high risk of recurrence of stage I gastric cancer. Korean J Intern Med 2021;36:1327-37. [PMID: 34428882 DOI: 10.3904/kjim.2020.243] [Reference Citation Analysis]
13 Jing Z, Nan KJ, Hu ML. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma. World J Gastroenterol 2005; 11(13): 1910-1916 [PMID: 15800979 DOI: 10.3748/wjg.v11.i13.1910] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
14 Al-Moundhri MS, Nirmala V, Al-Hadabi I, Al-Mawaly K, Burney I, Al-Nabhani M, Thomas V, Ganguly SS, Grant C. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. J Surg Oncol. 2005;91:243-252. [PMID: 16121348 DOI: 10.1002/jso.20324] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
15 Bria E, De Manzoni G, Beghelli S, Tomezzoli A, Barbi S, Di Gregorio C, Scardoni M, Amato E, Frizziero M, Sperduti I, Corbo V, Brunelli M, Bersani S, Tortora G, Scarpa A. A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status. Ann Oncol. 2013;24:693-701. [PMID: 23131390 DOI: 10.1093/annonc/mds506] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
16 Wang Y, Xiao H, Wang C, Wu H, He H, Yao C, Cui J, Li W. M-phase phosphoprotein 8 promotes gastric cancer growth and metastasis via p53/Bcl-2 and EMT-related signaling pathways. J Cell Biochem 2020;121:2330-42. [PMID: 31692032 DOI: 10.1002/jcb.29456] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Wei K, Jiang L, Wei Y, Wang Y, Qian X, Dai Q, Guan Q. The prognostic significance of p53 expression in gastric cancer: a meta-analysis. J Cancer Res Clin Oncol 2015;141:735-48. [DOI: 10.1007/s00432-014-1844-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
18 Babacan NA, Egilmez HR, Yücel B, Ilknur P, Seker MM, Kacan T, Bahceci A, Cihan S, Akinci B, Eriten B, Kilickap S. The prognostic value of UHRF-1 and p53 in gastric cancer. Saudi J Gastroenterol 2016;22:25-9. [PMID: 26831603 DOI: 10.4103/1319-3767.173755] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]